Filter
963
Filtered Results: 963
Text search:
European
Public
Health
Alliance
Featured
Recommendations
70
New Publications
187
Language
Document type
No document type
435
Studies & Reports
276
Guidelines
103
Manuals
56
Strategic & Response Plan
46
Training Material
24
Fact sheets
8
Situation Updates
7
Brochures
3
Resource Platforms
3
App
1
Online Courses
1
Countries / Regions
Global
85
Western and Central Europe
29
Africa
16
Kenya
15
Ukraine
15
Syria
15
Myanmar / Burma
14
Sierra Leone
13
Latin America and the Carribbean
13
Zambia
12
India
12
Uganda
11
Eastern Europe
11
Ethiopia
10
Liberia
10
Nepal
9
Ghana
8
Nigeria
8
Asia
8
Lesotho
7
Congo, Democratic Republic of
7
South–East Asia Region
7
South Sudan
7
Tanzania
6
Yemen
6
Burkina Faso
5
West and Central Africa
5
East and Southern Africa
5
Russia
5
Zimbabwe
4
Guinea
4
Haiti
4
Venezuela
4
Jordan
4
Middle East and North Africa
4
Lebanon
4
Bangladesh
4
South Africa
4
Namibia
4
Central African Republic
4
Colombia
3
China
3
Rwanda
3
Senegal
3
Afghanistan
3
Malawi
3
Cambodia
3
Germany
3
Eastern Europe and Central Asia
3
Georgia
3
Indonesia
3
Somalia
3
Thailand
2
Cameroon
2
Iran
2
Albania
2
Niger
2
Mozambique
2
USA
2
Vietnam
2
Sri Lanka
2
Eswatini/ Swaziland
2
Pakistan
2
Switzerland
1
Mexico
1
Benin
1
Canada
1
Laos
1
Estonia
1
Burundi
1
Peru
1
Philippines
1
Ireland
1
Western Pacific Region
1
Paraguay
1
United Kingdom
1
Southern Africa
1
Bolivia
1
Papua New Guinea
1
Moldova
1
Egypt
1
Sudan
1
Romania
1
Palestine
1
Poland
1
Mali
1
Libya
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
189
Public Health
81
Clinical Guidelines
71
Key Resources
56
Women & Child Health
37
Capacity Building
11
Pharmacy & Technologies
7
Toolboxes
Mental Health
113
HIV
84
COVID-19
75
Planetary Health
70
Disability
56
TB
46
Health Financing Toolbox
44
Global Health Education
44
AMR
44
NCDs
34
Conflict
27
Rapid Response
21
Caregiver
21
Refugee
20
Pharmacy
20
NTDs
19
Ebola & Marburg
16
Natural Hazards
7
Polio
6
Social Ethics
4
Cholera
3
Zika
3
Specific Hazards
2
Malaria
1
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Guidelines
June 2017
HIV strategic information for impact
Доклад ВОЗ о глобальной табачной эпидемии, 2009 год: Создание среды, свободной от табачного дыма, – второй из серии докладов ВОЗ, в которых определяется состояние таб...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated ...
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national and local levels, 14 March 2022
Based on the survey, five principles for deinstitutionalization were identified: community-based services must be in place; the health workforce must be committed to change; political support at the highest and broadest levels is crucial; timing is key; and additional financial resources are needed.
The key to a lasting world free of all forms of poliovirus lies in rapidly interrupting all remaining endemic transmission of WPV in the endemic areas of Pakistan and Afghanistan. This is the only way to ensure that such strains do not re-emerge globally through international spread. It lays the cor...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up...
